Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study

Marleen A. Slim,Rombout B. E. van Amstel,Lieuwe D. J. Bos,Olaf L. Cremer,Friso M. de Beer,Lieuwe D. J. Bos,Gerie J. Glas,Arie J. Hoogendijk,Roosmarijn T. M. van Hooijdonk,Janneke Horn,Mischa A. Huson,Laura R. A. Schouten,Marcus J. Schultz,Brendon P. Scicluna,Marleen Straat,Lonneke A. van Vught,Luuk Wieske,Maryse A. Wiewel,Esther Witteveen. Marc J. M. Bonten,Olaf M. Cremer,David S. Y. Ong,Jos F. Frencken,Peter M. C. Klein Klouwenberg,Maria E. Koster‐Brouwer,Kirsten van de Groep,Diana M. Verboom,W. Joost Wiersinga,Tom van der Poll,Lonneke A. van Vught,MARS Consortium
DOI: https://doi.org/10.1186/s13054-024-04929-9
IF: 15.1
2024-05-09
Critical Care
Abstract:Intensive care unit (ICU)-survivors have an increased risk of mortality after discharge compared to the general population. On ICU admission subphenotypes based on the plasma biomarker levels of interleukin-8, protein C and bicarbonate have been identified in patients admitted with acute respiratory distress syndrome (ARDS) that are prognostic of outcome and predictive of treatment response. We hypothesized that if these inflammatory subphenotypes previously identified among ARDS patients are assigned at ICU discharge in a more general critically ill population, they are associated with short- and long-term outcome.
critical care medicine
What problem does this paper attempt to address?